Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker

Boehringer Ingelheim RCV GmbH & Co. KG., Vienna, Austria (F.S., G.D., A.Z., G.B., M.S., C.K., O.K., E.H., G.R.A.); and Boehringer Ingelheim Pharma GmbH & Co. KG., Biberach/Riss, Germany (F.H.)

Address correspondence to:
Flavio Solca, Doktor-Böhringer-Gasse 5-11, A-1120, Vienna, Austria, E-mail: flavio.solca{at}boehringer-ingelheim.com

↵¹Current affiliation: AstraZeneca R&D, Mölndal, Sweden.

View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2012 to July 2021

	Abstract	Full	Pdf
Aug 2012	257	0	193
Sep 2012	118	4	237
Oct 2012	553	61	241
Nov 2012	428	65	134
Dec 2012	145	36	96
Jan 2013	164	37	93
Feb 2013	150	31	83
Mar 2013	152	31	108
Apr 2013	133	39	63
May 2013	96	28	64
Jun 2013	76	38	85
Jul 2013	94	44	96
Aug 2013	131	42	72
Sep 2013	152	44	95
Oct 2013	235	45	93
Nov 2013	90	97	168
Dec 2013	75	103	98
Jan 2014	55	100	121
Feb 2014	71	100	123
Mar 2014	93	121	118
Apr 2014	105	90	183
May 2014	86	140	197
Jun 2014	57	142	113
Jul 2014	86	127	102
Aug 2014	55	122	92
Sep 2014	70	120	111
Oct 2014	79	103	121
Nov 2014	103	119	97
Dec 2014	82	85	65
Jan 2015	75	90	80
Feb 2015	63	70	83
Mar 2015	86	139	93
Apr 2015	71	152	102
May 2015	79	142	107
Jun 2015	80	182	87
Jul 2015	53	104	101
Aug 2015	49	103	82
Sep 2015	61	144	91
Oct 2015	62	119	82
Nov 2015	76	131	122
Dec 2015	77	125	86
Jan 2016	101	112	104
Feb 2016	78	117	87
Mar 2016	83	143	117
Apr 2016	85	124	96
May 2016	70	125	107
Jun 2016	71	115	142
Jul 2016	72	123	131
Aug 2016	87	123	100
Sep 2016	56	134	71
Oct 2016	45	189	95
Nov 2016	36	139	92
Dec 2016	13	133	81
Jan 2017	27	155	74
Feb 2017	21	150	89
Mar 2017	23	197	92
Apr 2017	33	125	77
May 2017	35	106	86
Jun 2017	23	142	77
Jul 2017	28	142	88
Aug 2017	23	201	77
Sep 2017	21	119	65
Oct 2017	30	111	85
Nov 2017	32	135	54
Dec 2017	25	121	63
Jan 2018	29	124	81
Feb 2018	33	113	61
Mar 2018	39	150	95
Apr 2018	29	125	88
May 2018	25	140	69
Jun 2018	15	119	48
Jul 2018	24	85	69
Aug 2018	20	101	55
Sep 2018	14	91	54
Oct 2018	21	156	80
Nov 2018	16	133	61
Dec 2018	156	44	36
Jan 2019	150	28	16
Feb 2019	136	31	30
Mar 2019	205	33	38
Apr 2019	237	20	17
May 2019	133	14	17
Jun 2019	211	25	25
Jul 2019	177	30	26
Aug 2019	134	19	31
Sep 2019	115	34	22
Oct 2019	155	35	30
Nov 2019	195	39	23
Dec 2019	209	14	18
Jan 2020	144	17	15
Feb 2020	161	13	12
Mar 2020	148	22	28
Apr 2020	288	43	32
May 2020	248	30	30
Jun 2020	121	9	14
Jul 2020	160	9	17
Aug 2020	111	14	18
Sep 2020	145	7	11
Oct 2020	148	18	18
Nov 2020	166	16	17
Dec 2020	169	11	19
Jan 2021	192	21	24
Feb 2021	129	28	24
Mar 2021	238	35	32
Apr 2021	226	22	14
May 2021	275	21	37
Jun 2021	167	16	20
Jul 2021	149	12	15